Gault Laura has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 685 shares of Sage Therapeutics, Inc. ($SAGE) on February 13, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2025 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | F | Common Stock | 685 | $7.18 | 34,649.0000 | 61,480,947 | 1.94% | 0.00% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | A | Common Stock | 24000 | $0.00 | 35,334.0000 | 0 | 211.75% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | A | Common Stock | 13500 | $0.00 | 14,025.0000 | 0 | 2571.43% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | F | Common Stock | 3288 | $8.96 | 10,737.0000 | 0 | 23.44% | 0.00% |
| Feb. 13, 2024 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | A | Common Stock | 11250 | $0.00 | 11,477.0000 | 0 | 4955.95% | 0.00% |
| Feb. 13, 2024 | Sage Therapeutics, Inc. | $SAGE | Gault Laura | Chief Medical Officer | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |